ClinicalTrials.Veeva

Menu

Effects Of Income Supplements On 30-Day Readmissions For Vulnerable Older Adults

A

AltaMed Health Services

Status

Terminated

Conditions

Patient Readmission

Treatments

Other: Post-discharge income supplement
Other: Enhanced care planning

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05807750
2023-001 Sonik Readmit RCT
P30AG024968 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Unplanned 30-day hospital readmissions are an critical healthcare quality metric, with meaningful effects on patients and health systems operations. Interventions to reduce unplanned readmissions have primarily operated within a healthcare-centric frame, with enhancements to either pre- or post-discharge care planning, medication reconciliation, or visit frequency. Associations of 30-day readmission rates with poverty status and other social factors, however, suggest that attending to unmet social needs may yield added benefits to models focused on healthcare delivery. The purpose of the present trial is to provide evidence regarding the effects on 30-day readmissions of providing a one-time post-discharge income supplement to socially vulnerable older adults with medical complexity participating in an enhanced care coordination program.

Enrollment

8 patients

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A participant in the underlying enhanced care planning program
  • aged 55 years or older
  • attending an outpatient clinic appointment as part of the underlying enhanced care planning program within 10 days of being discharged from an inpatient hospital stay
  • able to understand the study consent form (with interpretation services if needed)

Exclusion criteria

  • The candidate is not discharged from the index admission to a community setting (e.g., they will be excluded if they are discharged to a skilled nursing facility)
  • The candidate has a legal guardian with control over financial decision-making
  • The candidate has been approached about the study during a previous encounter
  • The index hospitalization was a planned admission

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

8 participants in 2 patient groups

Control
Active Comparator group
Description:
Enhanced care planning only (plus $15 as compensation for participation)
Treatment:
Other: Enhanced care planning
Intervention
Experimental group
Description:
Enhanced care planning plus a one-time $300 post-discharge income supplement
Treatment:
Other: Enhanced care planning
Other: Post-discharge income supplement

Trial contacts and locations

1

Loading...

Central trial contact

Rajan A Sonik, PhD, JD, MPH; Joanna Garcia, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems